Franziska Jannasch
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Franziska Jannasch has a total of 238 co-authors. Here are the top co-authors by number of shared publications:
- Matthias B. Schulze
Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany
19 shared publications - Anne Tjønneland
Danish Cancer Institute, Copenhagen, Denmark
4 shared publications - Christina Catherine Dahm
Department of Public Health, Aarhus University, Aarhus, Denmark
4 shared publications - Birte Lindstädt
German National Library of Medicine
3 shared publications - Carina Nina Vorisek
Berlin Institute of Health at Charité – Universitätsmedizin Berlin
3 shared publications - Carolina Schwedhelm
Pfizer Pharma GmbH, Friedrichstraße 110, 10117, Berlin, Germany.
3 shared publications
Latest Publications
- Open Access
- 16 November 2026
- Published by Springer Nature in European Journal of Epidemiology
Advancing FAIR sharing for epidemiological, clinical and public health study data: the German National Research Data Infrastructure (NFDI4Health)
Access to high-quality, FAIR health data is essential for advancing epidemiological, public health and clinical research. NFDI4Health, one of the consortia of Germany’s National Research Data Infrastructure (NFDI), was established in 2020 to address this need by improving data FAIRness for the scientific community. During the initial funding phase, NFDI4Health developed key infrastructure components and services focusing on interoperability, data sharing and research support. Our approach was guided by user needs and real-world use cases in alignment with (inter)national FAIR standards and infrastructures. We advanced findability of health data by establishing a central Health Study Hub and connecting it to local infrastructures, e.g., through the Local Data Hub software, to facilitate transfer of metadata from the local infrastructures to the Health Study Hub. Accessibility was improved by expanding the German Research Data Portal for Health (FDPG) to provide central access to study data and by providing tools to support anonymisation and synthetic data generation. We also developed an interoperable metadata schema for publishing study data and implemented it in the Health Study Hub. To further improve interoperability, a NFDI4Health FAIR sharing collection and AI support for metadata annotation and harmonisation workflows were established. To enhance reusability, data quality assessment tools were further developed, and two frameworks for federated analysis of sensitive health data were piloted. Intensive engagement with our communities through training, advisory services, and collaborative development ensured user relevance. NFDI4Health has established a scalable, interoperable, and user-centred infrastructure to support FAIR data sharing in health research. Future work will focus on further developing and consolidating the infrastructure, expanding cross-domain data integration, fostering broader adoption within our research community, and strengthening national and international collaboration.
- 16 November 2026
- Published by Springer Nature in European Journal of Epidemiology
Open AccessAdvancing FAIR sharing for epidemiological, clinical and public health study data: the German National Research Data Infrastructure (NFDI4Health)
Access to high-quality, FAIR health data is essential for advancing epidemiological, public health and clinical research. NFDI4Health, one of the consortia of Germany’s National Research Data Infrastructure (NFDI), was established in 2020 to address this need by improving data FAIRness for the scientific community. During the initial funding phase, NFDI4Health developed key infrastructure components and services focusing on interoperability, data sharing and research support. Our approach was guided by user needs and real-world use cases in alignment with (inter)national FAIR standards and infrastructures. We advanced findability of health data by establishing a central Health Study Hub and connecting it to local infrastructures, e.g., through the Local Data Hub software, to facilitate transfer of metadata from the local infrastructures to the Health Study Hub. Accessibility was improved by expanding the German Research Data Portal for Health (FDPG) to provide central access to study data and by providing tools to support anonymisation and synthetic data generation. We also developed an interoperable metadata schema for publishing study data and implemented it in the Health Study Hub. To further improve interoperability, a NFDI4Health FAIR sharing collection and AI support for metadata annotation and harmonisation workflows were established. To enhance reusability, data quality assessment tools were further developed, and two frameworks for federated analysis of sensitive health data were piloted. Intensive engagement with our communities through training, advisory services, and collaborative development ensured user relevance. NFDI4Health has established a scalable, interoperable, and user-centred infrastructure to support FAIR data sharing in health research. Future work will focus on further developing and consolidating the infrastructure, expanding cross-domain data integration, fostering broader adoption within our research community, and strengthening national and international collaboration.
- Open Access
- 28 April 2026
- Published by Springer Nature in European Journal of Nutrition
- Vol. 65 (4) , 125
Systematic review of diet quality scores including diet diversity in relation to major chronic diseases, obesity and mortality in healthy adults
Purpose Diet diversity is highlighted in dietary guidelines, yet diverse diets can vary substantially in quality. Understanding its role within overall diet quality is essential. This systematic review investigated diet quality scores incorporating a distinct diet diversity component (DQDS) and their associations with type 2 diabetes (T2D), cancer, cardiovascular diseases (CVD), obesity and all-cause mortality among healthy adults in high-income Western countries. Methods A systematic search of the NCBI Database up to October 2025 identified prospective studies quantifying dietary intake and assessing a priori defined DQDS in relation to the outcomes of interest. Study quality was evaluated using the Scottish Intercollegiate Guidelines Network checklist. Due to substantial heterogeneity, findings were synthesised narratively. Results Sixteen reports were included, applying eight DQDS, including the original Healthy Eating Index, Diet Quality Index variants, national Dietary Guidelines Indices and the Healthy Food Diversity-Index. Considerable variability existed in the diet quality dimensions measured (adequacy, balance, moderation, diversity) and in how diet diversity was operationalised (simple food-group counts or evenness-based metrics). Associations between DQDS and all-cause mortality (n = 5), cancer (n = 4), CVD (n = 3), obesity (n = 4) and T2D (n = 3) were inconsistent, with studies reporting null or inverse relationships. Conclusion Current evidence remains insufficient to determine whether diet quality scores that include diet diversity are linked to chronic disease outcomes. Heterogeneity in the conceptualisation of both diet quality and diet diversity limits comparability across studies, highlighting the need for conceptually aligned, multidimensional DQDS in future research to clarify these relationships.
- 28 April 2026
- Published by Springer Nature in European Journal of Nutrition
- Vol. 65 (4) , 125
Open AccessSystematic review of diet quality scores including diet diversity in relation to major chronic diseases, obesity and mortality in healthy adults
Purpose Diet diversity is highlighted in dietary guidelines, yet diverse diets can vary substantially in quality. Understanding its role within overall diet quality is essential. This systematic review investigated diet quality scores incorporating a distinct diet diversity component (DQDS) and their associations with type 2 diabetes (T2D), cancer, cardiovascular diseases (CVD), obesity and all-cause mortality among healthy adults in high-income Western countries. Methods A systematic search of the NCBI Database up to October 2025 identified prospective studies quantifying dietary intake and assessing a priori defined DQDS in relation to the outcomes of interest. Study quality was evaluated using the Scottish Intercollegiate Guidelines Network checklist. Due to substantial heterogeneity, findings were synthesised narratively. Results Sixteen reports were included, applying eight DQDS, including the original Healthy Eating Index, Diet Quality Index variants, national Dietary Guidelines Indices and the Healthy Food Diversity-Index. Considerable variability existed in the diet quality dimensions measured (adequacy, balance, moderation, diversity) and in how diet diversity was operationalised (simple food-group counts or evenness-based metrics). Associations between DQDS and all-cause mortality (n = 5), cancer (n = 4), CVD (n = 3), obesity (n = 4) and T2D (n = 3) were inconsistent, with studies reporting null or inverse relationships. Conclusion Current evidence remains insufficient to determine whether diet quality scores that include diet diversity are linked to chronic disease outcomes. Heterogeneity in the conceptualisation of both diet quality and diet diversity limits comparability across studies, highlighting the need for conceptually aligned, multidimensional DQDS in future research to clarify these relationships.
- Open Access
- 1 November 2025
- Published by Oxford University Press (OUP) in Nutrition Reviews
- Vol. 84 (11) , 2434-2451
Scoping Review of Dietary Quality Indices: Heterogeneity of Definitions and Health Associations among Adults
The application of dietary quality indices (DQIs) is limited by inconsistent methods and suboptimal reporting, but the effect of index composition heterogeneity on the strength of disease associations is not clear. A scoping review was carried out to identify evidence on the most common disease-related DQIs and assess the heterogeneity of their application and its possible implications. We systematically identified umbrella reviews, systematic reviews, and primary studies that investigated the association of DQIs with all-cause mortality, risk of or mortality from cardiovascular diseases, type 2 diabetes, and cancer among adults. Compositions of the prioritized DQIs were explored in primary studies and the degree of deviance from the original DQI versions was quantified. A meta-regression was conducted to investigate the association between the degree of score modification and disease risk estimates. From 175 eligible primary studies, 51 DQIs were identified and retrieved from 20 systematic reviews included in 2 umbrella reviews. The most common indices were the Mediterranean diet (MedDiet scores), Alternative Healthy Eating Index (AHEI), Dietary Approaches to Stop Hypertension (DASH), Healthy Eating Index (HEI), and Dietary Inflammatory Index (DII). Higher diet quality reflected by these indices was associated with beneficial health outcomes in 17 meta-analyses. Heterogeneity of MedDiet scores was not considered, because it has been addressed in previous reviews. Substantial heterogeneity was identified in the remaining DQI applications. Among studies that reported composition details, AHEI-2010 and DII were modified in almost all studies, and DASH and HEI-2015 in half of the studies. The underlying reasons were mainly related to population- and study-specific characteristics. DQI modifications did not appear to substantially influence the direction or strength of associations with mortality and disease risk. However, heterogeneity of index composition and its suboptimal reporting limit the reproducibility and comparability of results from studies on DQIs and health outcomes, and standard applications are preferred.
- 1 November 2025
- Published by Oxford University Press (OUP) in Nutrition Reviews
- Vol. 84 (11) , 2434-2451
Open AccessScoping Review of Dietary Quality Indices: Heterogeneity of Definitions and Health Associations among Adults
The application of dietary quality indices (DQIs) is limited by inconsistent methods and suboptimal reporting, but the effect of index composition heterogeneity on the strength of disease associations is not clear. A scoping review was carried out to identify evidence on the most common disease-related DQIs and assess the heterogeneity of their application and its possible implications. We systematically identified umbrella reviews, systematic reviews, and primary studies that investigated the association of DQIs with all-cause mortality, risk of or mortality from cardiovascular diseases, type 2 diabetes, and cancer among adults. Compositions of the prioritized DQIs were explored in primary studies and the degree of deviance from the original DQI versions was quantified. A meta-regression was conducted to investigate the association between the degree of score modification and disease risk estimates. From 175 eligible primary studies, 51 DQIs were identified and retrieved from 20 systematic reviews included in 2 umbrella reviews. The most common indices were the Mediterranean diet (MedDiet scores), Alternative Healthy Eating Index (AHEI), Dietary Approaches to Stop Hypertension (DASH), Healthy Eating Index (HEI), and Dietary Inflammatory Index (DII). Higher diet quality reflected by these indices was associated with beneficial health outcomes in 17 meta-analyses. Heterogeneity of MedDiet scores was not considered, because it has been addressed in previous reviews. Substantial heterogeneity was identified in the remaining DQI applications. Among studies that reported composition details, AHEI-2010 and DII were modified in almost all studies, and DASH and HEI-2015 in half of the studies. The underlying reasons were mainly related to population- and study-specific characteristics. DQI modifications did not appear to substantially influence the direction or strength of associations with mortality and disease risk. However, heterogeneity of index composition and its suboptimal reporting limit the reproducibility and comparability of results from studies on DQIs and health outcomes, and standard applications are preferred.
- Open Access
- 27 May 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Correction: Toward a Domain-Overarching Metadata Schema for Making Health Research Studies FAIR (Findable, Accessible, Interoperable, and Reusable): Development of the NFDI4Health Metadata Schema (Preprint)
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author).
- 27 May 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessCorrection: Toward a Domain-Overarching Metadata Schema for Making Health Research Studies FAIR (Findable, Accessible, Interoperable, and Reusable): Development of the NFDI4Health Metadata Schema (Preprint)
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author).
- Open Access
- 21 May 2025
- Published by JMIR Publications Inc. in JMIR Medical Informatics
- Vol. 13, e63906
Toward a Domain-Overarching Metadata Schema for Making Health Research Studies FAIR (Findable, Accessible, Interoperable, and Reusable): Development of the NFDI4Health Metadata Schema
Background: Despite wide acceptance in medical research, implementation of the FAIR (findability, accessibility, interoperability, and reusability) principles in certain health domains and interoperability across data sources remain a challenge. While clinical trial registries collect metadata about clinical studies, numerous epidemiological and public health studies remain unregistered or lack detailed information about relevant study documents. Making valuable data from these studies available to the research community could improve our understanding of various diseases and their risk factors. The National Research Data Infrastructure for Personal Health Data (NFDI4Health) seeks to optimize data sharing among the clinical, epidemiological, and public health research communities while preserving privacy and ethical regulations. Objective: We aimed to develop a tailored metadata schema (MDS) to support the standardized publication of health studies’ metadata in NFDI4Health services and beyond. This study describes the development, structure, and implementation of this MDS designed to improve the FAIRness of metadata from clinical, epidemiological, and public health research while maintaining compatibility with metadata models of other resources to ease interoperability. Methods: Based on the models of DataCite, ClinicalTrials.gov, and other data models and international standards, the first MDS version was developed by the NFDI4Health Task Force COVID-19. It was later extended in a modular fashion, combining generic and NFDI4Health use case–specific metadata items relevant to domains of nutritional epidemiology, chronic diseases, and record linkage. Mappings to schemas of clinical trial registries and international and local initiatives were performed to enable interfacing with external resources. The MDS is represented in Microsoft Excel spreadsheets. A transformation into an improved and interactive machine-readable format was completed using the ART-DECOR (Advanced Requirement Tooling-Data Elements, Codes, OIDs, and Rules) tool to facilitate editing, maintenance, and versioning. Results: The MDS is implemented in NFDI4Health services (eg, the German Central Health Study Hub and the Local Data Hub) to structure and exchange study-related metadata. Its current version (3.3) comprises 220 metadata items in 5 modules. The core and design modules cover generic metadata, including bibliographic information, study design details, and data access information. Domain-specific metadata are included in use case–specific modules, currently comprising nutritional epidemiology, chronic diseases, and record linkage. All modules incorporate mandatory, optional, and conditional items. Mappings to the schemas of clinical trial registries and other resources enable integrating their study metadata in the NFDI4Health services. The current MDS version is available in both Excel and ART-DECOR formats. Conclusions: With its implementation in the German Central Health Study Hub and the Local Data Hub, the MDS improves the FAIRness of data from clinical, epidemiological, and public health research. Due to its generic nature and interoperability through mappings to other schemas, it is transferable to services from adjacent domains, making it useful for a broader user community.
- 21 May 2025
- Published by JMIR Publications Inc. in JMIR Medical Informatics
- Vol. 13, e63906
Open AccessToward a Domain-Overarching Metadata Schema for Making Health Research Studies FAIR (Findable, Accessible, Interoperable, and Reusable): Development of the NFDI4Health Metadata Schema
Background: Despite wide acceptance in medical research, implementation of the FAIR (findability, accessibility, interoperability, and reusability) principles in certain health domains and interoperability across data sources remain a challenge. While clinical trial registries collect metadata about clinical studies, numerous epidemiological and public health studies remain unregistered or lack detailed information about relevant study documents. Making valuable data from these studies available to the research community could improve our understanding of various diseases and their risk factors. The National Research Data Infrastructure for Personal Health Data (NFDI4Health) seeks to optimize data sharing among the clinical, epidemiological, and public health research communities while preserving privacy and ethical regulations. Objective: We aimed to develop a tailored metadata schema (MDS) to support the standardized publication of health studies’ metadata in NFDI4Health services and beyond. This study describes the development, structure, and implementation of this MDS designed to improve the FAIRness of metadata from clinical, epidemiological, and public health research while maintaining compatibility with metadata models of other resources to ease interoperability. Methods: Based on the models of DataCite, ClinicalTrials.gov, and other data models and international standards, the first MDS version was developed by the NFDI4Health Task Force COVID-19. It was later extended in a modular fashion, combining generic and NFDI4Health use case–specific metadata items relevant to domains of nutritional epidemiology, chronic diseases, and record linkage. Mappings to schemas of clinical trial registries and international and local initiatives were performed to enable interfacing with external resources. The MDS is represented in Microsoft Excel spreadsheets. A transformation into an improved and interactive machine-readable format was completed using the ART-DECOR (Advanced Requirement Tooling-Data Elements, Codes, OIDs, and Rules) tool to facilitate editing, maintenance, and versioning. Results: The MDS is implemented in NFDI4Health services (eg, the German Central Health Study Hub and the Local Data Hub) to structure and exchange study-related metadata. Its current version (3.3) comprises 220 metadata items in 5 modules. The core and design modules cover generic metadata, including bibliographic information, study design details, and data access information. Domain-specific metadata are included in use case–specific modules, currently comprising nutritional epidemiology, chronic diseases, and record linkage. All modules incorporate mandatory, optional, and conditional items. Mappings to the schemas of clinical trial registries and other resources enable integrating their study metadata in the NFDI4Health services. The current MDS version is available in both Excel and ART-DECOR formats. Conclusions: With its implementation in the German Central Health Study Hub and the Local Data Hub, the MDS improves the FAIRness of data from clinical, epidemiological, and public health research. Due to its generic nature and interoperability through mappings to other schemas, it is transferable to services from adjacent domains, making it useful for a broader user community.
- Open Access
Diabetes-Related Dietary Patterns and Endometrial Cancer Risk and Survival in the European Prospective Investigation into Cancer and Nutrition Study
Background/Objectives: Endometrial cancer (EC)’s major risk factors include obesity and diabetes, both strongly related with lifestyle choices and dietary factors. Our study aimed to evaluate the relationship between diabetes-related dietary patterns, EC risk, and survival in a population of middle-aged European women. Methods: A total of 285,418 female participants from the European Prospective Investigation into Cancer and Nutrition (EPIC) study were included in the analysis. After a mean time of 10.6 years of follow-up, 1955 incident EC cases were registered; of those, 133 women died from EC. The Empirical Dietary Index for Insulin Resistance (EDIR), the Empirical Dietary Index for Hyperinsulinemia (EDIH), and the Diabetes Risk Reduction Diet (DRRD), were estimated from dietary information collected at baseline from EPIC participants. Cox proportional hazards regression models were used to evaluate the association between the dietary patterns and EC risk, using hazard ratios (HR), 95% confidence intervals (CI), and adjusting for relevant confounders. Cox and Fine–Gray models were used to assess the association with overall and EC-specific mortality, respectively. Results: Higher adherence to EDIR was associated with an increased risk of EC, multivariable HR for T3vsT1 were 1.17 (95% CI = 1.04 to1.31). However, when BMI was included in the models, these associations became weaker and no longer statistically significant. No associations were observed in relation to adherence to EDIH, DRRD, and EC risk. No associations were found in relation to diabetes-related dietary patterns and mortality. Conclusions: This study highlights the potential role of diabetes related dietary patterns and EC etiology and prevention. Further studies are warranted to better understand the role of etiology-derived dietary patterns and disease prevention and prognosis.
Open AccessDiabetes-Related Dietary Patterns and Endometrial Cancer Risk and Survival in the European Prospective Investigation into Cancer and Nutrition Study
Background/Objectives: Endometrial cancer (EC)’s major risk factors include obesity and diabetes, both strongly related with lifestyle choices and dietary factors. Our study aimed to evaluate the relationship between diabetes-related dietary patterns, EC risk, and survival in a population of middle-aged European women. Methods: A total of 285,418 female participants from the European Prospective Investigation into Cancer and Nutrition (EPIC) study were included in the analysis. After a mean time of 10.6 years of follow-up, 1955 incident EC cases were registered; of those, 133 women died from EC. The Empirical Dietary Index for Insulin Resistance (EDIR), the Empirical Dietary Index for Hyperinsulinemia (EDIH), and the Diabetes Risk Reduction Diet (DRRD), were estimated from dietary information collected at baseline from EPIC participants. Cox proportional hazards regression models were used to evaluate the association between the dietary patterns and EC risk, using hazard ratios (HR), 95% confidence intervals (CI), and adjusting for relevant confounders. Cox and Fine–Gray models were used to assess the association with overall and EC-specific mortality, respectively. Results: Higher adherence to EDIR was associated with an increased risk of EC, multivariable HR for T3vsT1 were 1.17 (95% CI = 1.04 to1.31). However, when BMI was included in the models, these associations became weaker and no longer statistically significant. No associations were observed in relation to adherence to EDIH, DRRD, and EC risk. No associations were found in relation to diabetes-related dietary patterns and mortality. Conclusions: This study highlights the potential role of diabetes related dietary patterns and EC etiology and prevention. Further studies are warranted to better understand the role of etiology-derived dietary patterns and disease prevention and prognosis.
- 23 April 2025
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 105 (3) , 977-989
EPIC-Potsdam sub-cohort study: The early role of trace elements, oxidative stress, and anthropometrics in Alzheimer's disease and dementia onset
Background: Serum trace elements, anthropometric data, and oxidative stress markers are often altered in patients diagnosed with Alzheimer's disease (AD) or other types of dementia (OTD). However, these parameters are rarely examined together before disease onset in a single study population. Objective: This nested case-control study aims to investigate anthropometric data, serum trace elements, exchangeable copper (CuEXC), and oxidative stress markers to identify early associations with the risk of AD or OTD. Methods: From the European Prospective Investigation into Cancer and Nutrition-Potsdam cohort (DRKS-ID: DRKS00020593), the High Fat Diet, Microbiota, and Neuroinflammation in the Progression of Alzheimer study was generated. One hundred twenty-eight individuals who developed AD or OTD were identified, approximately 15.7 years after baseline data collection, and matched for age, sex, fasting status, and season of blood sampling with 512 controls. Serum levels of manganese (Mn), iron (Fe), copper (Cu), zinc (Zn), selenium (Se), iodine (I), CuEXC, and plasma malondialdehyde (MDA) and 3-nitrotyrosine (3-NT) were analyzed. Results: Cases and non-cases did not differ in anthropometric data or oxidative stress markers. Female cases exhibited a trend of elevated serum Cu and CuEXC levels compared to female non-cases. A higher Se/Cu ratio suggested an inverse association (OR = 0.72, 95% CI: 0.56–0.92), while an increased Cu/Zn ratio was positively associated (OR = 2.1, 95% CI: 1.1–4.1) with AD or OTD incidence. Conclusions: Ratios of serum trace elements, rather than individual levels, show early associations with the risk of AD or OTD while anthropometric and oxidative stress markers did not.
- 23 April 2025
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 105 (3) , 977-989
EPIC-Potsdam sub-cohort study: The early role of trace elements, oxidative stress, and anthropometrics in Alzheimer's disease and dementia onset
Background: Serum trace elements, anthropometric data, and oxidative stress markers are often altered in patients diagnosed with Alzheimer's disease (AD) or other types of dementia (OTD). However, these parameters are rarely examined together before disease onset in a single study population. Objective: This nested case-control study aims to investigate anthropometric data, serum trace elements, exchangeable copper (CuEXC), and oxidative stress markers to identify early associations with the risk of AD or OTD. Methods: From the European Prospective Investigation into Cancer and Nutrition-Potsdam cohort (DRKS-ID: DRKS00020593), the High Fat Diet, Microbiota, and Neuroinflammation in the Progression of Alzheimer study was generated. One hundred twenty-eight individuals who developed AD or OTD were identified, approximately 15.7 years after baseline data collection, and matched for age, sex, fasting status, and season of blood sampling with 512 controls. Serum levels of manganese (Mn), iron (Fe), copper (Cu), zinc (Zn), selenium (Se), iodine (I), CuEXC, and plasma malondialdehyde (MDA) and 3-nitrotyrosine (3-NT) were analyzed. Results: Cases and non-cases did not differ in anthropometric data or oxidative stress markers. Female cases exhibited a trend of elevated serum Cu and CuEXC levels compared to female non-cases. A higher Se/Cu ratio suggested an inverse association (OR = 0.72, 95% CI: 0.56–0.92), while an increased Cu/Zn ratio was positively associated (OR = 2.1, 95% CI: 1.1–4.1) with AD or OTD incidence. Conclusions: Ratios of serum trace elements, rather than individual levels, show early associations with the risk of AD or OTD while anthropometric and oxidative stress markers did not.
- Open Access
- 16 September 2024
- Published by Elsevier in The Lancet Regional Health - Europe
- Vol. 46, 101043
Food consumption by degree of food processing and risk of type 2 diabetes mellitus: a prospective cohort analysis of the European Prospective Investigation into Cancer and Nutrition (EPIC)
- 16 September 2024
- Published by Elsevier in The Lancet Regional Health - Europe
- Vol. 46, 101043
Open AccessFood consumption by degree of food processing and risk of type 2 diabetes mellitus: a prospective cohort analysis of the European Prospective Investigation into Cancer and Nutrition (EPIC)
- Open Access
- 17 June 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-10
Longitudinally changed diet quality scores and their association with type 2 diabetes mellitus and cardiovascular diseases in the EPIC-Potsdam study
Association analyses between longitudinal changes in diet quality scores (DQIs) and cardiometabolic risk remain scarce. Hence, we aimed to investigate how changes in two DQIs are associated with incident type 2 diabetes (T2D), myocardial infarction (MI) and stroke in the EPIC-Potsdam study. Changes in the Mediterranean Pyramid Score (MedPyr) and Healthy Diet Score (HDS) over 7 years from baseline (1994–1998) to follow-up 3 (2001–2005) were investigated in 23,548 middle-aged participants. Adjusted Cox Proportional Hazards Regression models were applied to investigate associations between changes in MedPyr and HDS and chronic disease incidence. More than 60% of the participants increased both DQIs more than 5%. Within a median follow-up time of 5 years 568 cases of T2D, 171 of MI, 189 of stroke were verified. An increased compared to stable MedPyr was associated with lower T2D risk (HR 0.74; 95% CI 0.59–0.92), while a decreased MedPyr was associated with higher stroke risk (HR 1.67; 95% CI 1.02–2.72). A decreased compared to stable HDS was associated with higher stroke risk (HR 1.80; 95% CI 1.02–3.20). The findings contribute further evidence on advantages of changing dietary intake towards a Mediterranean Diet. Although baseline HDS adherence was associated with T2D and stroke risk, longitudinal changes in HDS were only significantly associated with stroke risk.
- 17 June 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-10
Open AccessLongitudinally changed diet quality scores and their association with type 2 diabetes mellitus and cardiovascular diseases in the EPIC-Potsdam study
Association analyses between longitudinal changes in diet quality scores (DQIs) and cardiometabolic risk remain scarce. Hence, we aimed to investigate how changes in two DQIs are associated with incident type 2 diabetes (T2D), myocardial infarction (MI) and stroke in the EPIC-Potsdam study. Changes in the Mediterranean Pyramid Score (MedPyr) and Healthy Diet Score (HDS) over 7 years from baseline (1994–1998) to follow-up 3 (2001–2005) were investigated in 23,548 middle-aged participants. Adjusted Cox Proportional Hazards Regression models were applied to investigate associations between changes in MedPyr and HDS and chronic disease incidence. More than 60% of the participants increased both DQIs more than 5%. Within a median follow-up time of 5 years 568 cases of T2D, 171 of MI, 189 of stroke were verified. An increased compared to stable MedPyr was associated with lower T2D risk (HR 0.74; 95% CI 0.59–0.92), while a decreased MedPyr was associated with higher stroke risk (HR 1.67; 95% CI 1.02–2.72). A decreased compared to stable HDS was associated with higher stroke risk (HR 1.80; 95% CI 1.02–3.20). The findings contribute further evidence on advantages of changing dietary intake towards a Mediterranean Diet. Although baseline HDS adherence was associated with T2D and stroke risk, longitudinal changes in HDS were only significantly associated with stroke risk.
- Open Access
- 19 March 2024
- Published by MDPI AG in Metabolites
- Vol. 14 (3) , 172
Association between Protein Intake and Diabetes Complications Risk Following Incident Type 2 Diabetes: The EPIC-Potsdam Study
Our knowledge about the connection between protein intake and diabetes-related complications comes largely from studies among those already diagnosed with type 2 diabetes (T2D). However, there is a lack of information on whether changing protein intake after diabetes diagnosis affects complications risk. We aimed to explore the association between protein intake (total, animal, and plant) and vascular complications in incident T2D patients considering pre-diagnosis intake and changes in intake after diagnosis. This prospective cohort study included 1064 participants from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam cohort who developed T2D during follow-up (physician-verified). Dietary protein intake was measured with a food frequency questionnaire at baseline and follow-up. We included physician-reported incident diabetes complications (myocardial infarction, stroke, nephropathy, and neuropathy). A total of 388 participants developed complications, 82 macrovascular complications, and 343 microvascular complications. Substituting carbohydrates with protein showed a trend towards lower complications risk, although this association was not statistically significant (hazard ratio (HR) for 5% energy (E) substitution: 0.83; 95% confidence intervals (CI): 0.60–1.14). Increasing protein intake at the expense of carbohydrates after diabetes diagnosis was not associated with total and microvascular complications (HR for 5% E change substitution: 0.98; 95% CI: 0.89–1.08 and HR for 5% E change substitution: 1.02; 95% CI: 0.92–1.14, respectively). Replacing carbohydrates with protein did not elevate the risk of diabetes complications in incident T2D cases.
- 19 March 2024
- Published by MDPI AG in Metabolites
- Vol. 14 (3) , 172
Open AccessAssociation between Protein Intake and Diabetes Complications Risk Following Incident Type 2 Diabetes: The EPIC-Potsdam Study
Our knowledge about the connection between protein intake and diabetes-related complications comes largely from studies among those already diagnosed with type 2 diabetes (T2D). However, there is a lack of information on whether changing protein intake after diabetes diagnosis affects complications risk. We aimed to explore the association between protein intake (total, animal, and plant) and vascular complications in incident T2D patients considering pre-diagnosis intake and changes in intake after diagnosis. This prospective cohort study included 1064 participants from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam cohort who developed T2D during follow-up (physician-verified). Dietary protein intake was measured with a food frequency questionnaire at baseline and follow-up. We included physician-reported incident diabetes complications (myocardial infarction, stroke, nephropathy, and neuropathy). A total of 388 participants developed complications, 82 macrovascular complications, and 343 microvascular complications. Substituting carbohydrates with protein showed a trend towards lower complications risk, although this association was not statistically significant (hazard ratio (HR) for 5% energy (E) substitution: 0.83; 95% confidence intervals (CI): 0.60–1.14). Increasing protein intake at the expense of carbohydrates after diabetes diagnosis was not associated with total and microvascular complications (HR for 5% E change substitution: 0.98; 95% CI: 0.89–1.08 and HR for 5% E change substitution: 1.02; 95% CI: 0.92–1.14, respectively). Replacing carbohydrates with protein did not elevate the risk of diabetes complications in incident T2D cases.